ArticleImmunotherapy2013

Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients.

Emmanuel Deshayes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.